3 ms·
It's not clear to me that this was in any way a money-making business. The test only needs to be taken once. Selling this data to 3rd parties by way of a sneaky
by rchaud 3y ago
It's not clear to me that this was in any way a money-making business. The test only needs to be taken once. Selling this data to 3rd parties by way of a sneaky EULA may be part of SV culture, but it's probably not something that would get you repeat business in healthcare.
- moralestapia 3y agoIt's weird to me because the test cost was always more than enough to make it profitable. This is the kind of product where you can actually make a profit on every sale (funny I have to make that remark but it's the 2020s) ... and then ... they didn't somehow? :/
- rchaud 3y agoThey cut the cost of the test from $399 to $99, so maybe their margins were not as good. Also, it would be a red flag to investors if there weren't any tacked-on "services" on top of the main offeirng to keep squeezing customers after the initial sale.